See more : Jounce Therapeutics, Inc. (JNCE) Income Statement Analysis – Financial Results
Complete financial analysis of Zydus Wellness Limited (ZYDUSWELL.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zydus Wellness Limited, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- PJSC Russian Aquaculture (AQUA.ME) Income Statement Analysis – Financial Results
- Eagers Automotive Limited (APE.AX) Income Statement Analysis – Financial Results
- Power & Digital Infrastructure Acquisition II Corp. (XPDB) Income Statement Analysis – Financial Results
- Pacific Financial Corporation (PFLC) Income Statement Analysis – Financial Results
- COSCO SHIPPING Holdings Co., Ltd. (CICOF) Income Statement Analysis – Financial Results
Zydus Wellness Limited (ZYDUSWELL.NS)
About Zydus Wellness Limited
Zydus Wellness Limited develops, produces, markets, and distributes health and wellness products in India. It provides sugar substitute products under the Sugar Free Gold, Sugar Free Natura, and Sugar Free Green brands; milk-based health food drink under the Complan brand; glucose-based beverage under the Glucon D brand; and Sugarlite, a blended sugar coated with stevia. The company also offers a range of skincare products, such as soap-free face washes, face masks, scrubs, and cleansers under the Everyuth brand; prickly heat and cooling powder, and hand sanitizer under the Nycil brand; and probiotic butter spread, table spread, ghee, butter, cholesterol fat-free spread, mayonnaise, and chocolate spread under the Nutralite brand. In addition, it exports its products. The company was formerly known as Carnation Nutra Analogue Foods Limited and changed its name to Zydus Wellness Limited in January 2009. The company was founded in 1988 and is based in Ahmedabad, India. Zydus Wellness Limited is a subsidiary of Cadila Healthcare Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.28B | 22.43B | 19.88B | 18.54B | 17.34B | 8.08B | 5.01B | 4.27B | 4.28B | 4.21B | 4.03B | 3.87B | 3.31B | 3.36B | 2.68B | 1.95B | 563.33M | 427.05M |
| Cost of Revenue | 11.54B | 11.46B | 9.87B | 8.55B | 7.88B | 3.00B | 1.63B | 1.35B | 1.23B | 1.27B | 1.26B | 1.26B | 1.17B | 1.20B | 862.20M | 727.27M | 306.75M | 249.73M |
| Gross Profit | 11.74B | 10.97B | 10.02B | 9.98B | 9.46B | 5.08B | 3.39B | 2.93B | 3.05B | 2.93B | 2.77B | 2.61B | 2.15B | 2.16B | 1.82B | 1.22B | 256.58M | 177.32M |
| Gross Profit Ratio | 50.43% | 48.90% | 50.39% | 53.86% | 54.55% | 62.86% | 67.51% | 68.52% | 71.31% | 69.72% | 68.75% | 67.43% | 64.79% | 64.27% | 67.84% | 62.65% | 45.55% | 41.52% |
| Research & Development | 48.00M | 85.00M | 94.60M | 111.50M | 100.00K | 22.10M | 190.96M | 10.98M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 375.00M | 181.30M | 504.10M | 506.40M | 130.30M | 172.70M | 49.20M | 39.60M | 53.60M | 74.50M | 78.70M | 5.50M | 1.38B | 1.32B | 1.15B | 833.40M | 194.72M | 136.81M |
| Selling & Marketing | 4.75B | 2.59B | 3.42B | 3.34B | 3.41B | 2.01B | 1.20B | 1.05B | 1.33B | 1.28B | 1.17B | 1.11B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.76B | 2.59B | 3.92B | 3.84B | 3.54B | 2.18B | 1.25B | 1.09B | 1.39B | 1.35B | 1.25B | 1.12B | 1.38B | 1.32B | 1.15B | 833.40M | 194.72M | 136.81M |
| Other Expenses | 0.00 | 48.60M | 104.00M | 89.40M | 2.98B | 1.28B | 974.20M | 917.10M | 820.30M | 656.70M | 665.70M | 574.80M | 90.10M | -57.20M | -43.60M | 5.98M | -8.45M | -6.78M |
| Operating Expenses | 5.74B | 7.85B | 6.79B | 6.80B | 6.52B | 3.46B | 2.22B | 2.01B | 2.21B | 2.01B | 1.92B | 1.69B | 1.33B | 1.26B | 1.10B | 839.37M | 186.27M | 130.03M |
| Cost & Expenses | 17.28B | 19.30B | 16.66B | 15.35B | 14.40B | 6.46B | 3.85B | 3.35B | 3.43B | 3.28B | 3.18B | 2.95B | 2.49B | 2.46B | 1.97B | 1.57B | 493.01M | 379.76M |
| Interest Income | 110.00M | 32.20M | 92.90M | 67.60M | 53.50M | 203.90M | 305.90M | 313.90M | 306.00M | 267.30M | 188.40M | 155.30M | 88.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 240.00M | 160.80M | 251.10M | 834.00M | 1.39B | 299.20M | 15.70M | 4.60M | 100.00K | 300.00K | 300.00K | 200.00K | 300.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 238.00M | 250.20M | 236.20M | 251.60M | 263.90M | 125.10M | 88.80M | 71.60M | 68.10M | 77.30M | 46.50M | 45.00M | 38.60M | 14.90M | 15.90M | 16.73M | 7.26M | 4.24M |
| EBITDA | 3.08B | 3.32B | 3.55B | 2.21B | 2.88B | 2.13B | 1.60B | 1.32B | 1.24B | 1.27B | 1.08B | 1.12B | 861.00M | 914.50M | 731.00M | 397.49M | 77.58M | 51.53M |
| EBITDA Ratio | 13.23% | 15.25% | 17.81% | 18.92% | 18.79% | 24.07% | 31.06% | 30.55% | 28.45% | 30.17% | 26.88% | 28.96% | 25.98% | 27.19% | 27.27% | 20.41% | 13.77% | 12.07% |
| Operating Income | 6.00B | 3.13B | 3.22B | 3.19B | 2.95B | 1.72B | 1.16B | 919.10M | 842.10M | 924.30M | 850.70M | 919.30M | 822.40M | 899.60M | 715.10M | 380.76M | 70.32M | 47.30M |
| Operating Income Ratio | 25.76% | 13.93% | 16.20% | 17.22% | 16.99% | 21.32% | 23.19% | 21.51% | 19.69% | 21.97% | 21.12% | 23.75% | 24.81% | 26.74% | 26.68% | 19.55% | 12.48% | 11.07% |
| Total Other Income/Expenses | -3.40B | -216.00M | -159.90M | -2.07B | -1.73B | -12.20M | -423.80M | -366.30M | -366.70M | -367.40M | 185.60M | 159.80M | 0.00 | 0.00 | -22.00M | -16.06M | -670.00K | -284.00K |
| Income Before Tax | 2.60B | 2.91B | 3.06B | 1.12B | 1.21B | 1.71B | 1.50B | 1.24B | 1.15B | 1.20B | 1.04B | 1.08B | 822.40M | 899.60M | 693.10M | 364.74M | 70.32M | 47.30M |
| Income Before Tax Ratio | 11.17% | 12.97% | 15.39% | 6.05% | 6.99% | 21.11% | 29.86% | 29.02% | 26.95% | 28.44% | 25.73% | 27.86% | 24.81% | 26.74% | 25.86% | 18.73% | 12.48% | 11.07% |
| Income Tax Expense | -68.00M | -195.10M | -28.50M | -65.20M | -204.50M | -6.10M | 132.30M | 127.20M | 115.60M | 85.00M | 53.20M | 88.30M | 136.50M | 304.80M | 240.40M | 126.72M | 24.77M | 23.40M |
| Net Income | 2.67B | 3.10B | 3.09B | 1.19B | 1.42B | 1.69B | 1.34B | 1.09B | 1.02B | 1.09B | 964.50M | 971.10M | 685.90M | 594.80M | 452.70M | 238.02M | 45.55M | 23.90M |
| Net Income Ratio | 11.47% | 13.84% | 15.53% | 6.41% | 8.17% | 20.93% | 26.70% | 25.50% | 23.78% | 25.89% | 23.95% | 25.09% | 20.69% | 17.68% | 16.89% | 12.22% | 8.09% | 5.60% |
| EPS | 41.94 | 48.78 | 48.54 | 19.55 | 24.58 | 40.10 | 34.27 | 27.89 | 26.43 | 27.88 | 24.69 | 24.85 | 17.32 | 15.22 | 11.59 | 6.09 | 8.17 | 7.66 |
| EPS Diluted | 41.94 | 48.78 | 48.54 | 19.55 | 24.58 | 40.10 | 34.27 | 27.89 | 26.43 | 27.88 | 24.69 | 24.85 | 17.32 | 15.22 | 11.59 | 6.09 | 8.17 | 7.66 |
| Weighted Avg Shares Out | 63.64M | 63.63M | 63.63M | 60.74M | 57.66M | 42.18M | 39.07M | 39.07M | 39.07M | 39.07M | 39.07M | 39.07M | 39.07M | 39.07M | 39.07M | 39.07M | 5.58M | 5.58M |
| Weighted Avg Shares Out (Dil) | 63.63M | 63.63M | 63.63M | 60.74M | 57.66M | 42.18M | 39.07M | 39.07M | 39.07M | 39.07M | 39.07M | 39.07M | 39.07M | 39.07M | 39.07M | 39.07M | 5.58M | 5.58M |
Source: https://incomestatements.info
Category: Stock Reports